|
Concord Drugs Ltd.
|
Nine Months RESULTS
|
|
|
You can view the
Nine Months Results
for the last 5 years.
|
Market Cap. (Rs.)
|
112.04 Cr.
|
P/BV
|
3.02
|
Book Value (Rs.)
|
28.13
|
|
52 Week High/Low (Rs.)
|
93/26
|
FV/ML
|
10/1
|
P/E(X)
|
333.49
|
|
Bookclosure
|
30/09/2024
|
EPS (Rs.)
|
0.26
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Net Sales/Income from operations | 34.85 | 29.28 |
| Total Income From Operations | 34.85 | 29.28 |
| | | |
| EXPENDITURE | | |
| Consumption of Raw Materials | 27.16 | 21.83 |
| Increase/Decrease in Stocks | 0.16 | -1.83 |
| Employees Cost | 3.40 | 4.39 |
| Depreciation | 1.05 | 1.16 |
| Other Expenses | 1.04 | 1.20 |
| Total Expenses | 32.81 | 26.75 |
| | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 2.04 | 2.53 |
| Other Income | 0.01 | 0.01 |
| P/L Before Interest, Excpt. Items & Tax | 2.05 | 2.54 |
| Interest | 1.42 | 1.36 |
| P/L Before Exceptional Items & Tax | 0.63 | 1.18 |
| P/L Before Tax | 0.63 | 1.18 |
| Tax | 0.34 | 0.37 |
| P/L After Tax from Ordinary Activities | 0.30 | 0.81 |
| Net Profit/Loss For the Period | 0.30 | 0.81 |
| Net P/L After Minority Interest & Share Of Associates | 0.30 | 0.81 |
| | | |
| Equity Share Capital | 10.00 | 10.00 |
| EPS Before Extra Ordinary * | | |
| Basic EPS (Rs.) | 0.30 | 0.81 |
| Diluted EPS (Rs.) | 0.30 | 0.81 |
| EPS After Extra Ordinary * | | |
| Basic EPS (Rs.) | 0.30 | 0.81 |
| Diluted EPS (Rs.) | 0.30 | 0.81 |
| | | |
| PBITOE Margin (%) | 5.85 | 8.64 |
| PBTE Margin (%) | 1.81 | 4.01 |
| PBT Margin (%) | 1.81 | 4.01 |
| PAT Margin (%) | 0.85 | 2.77 |
| PAT After MI And SOA Margin (%) | 0.85 | 2.77 |
